Share on StockTwits

Boulder Brands (NASDAQ:BDBD) has been given a consensus recommendation of “Buy” by the thirteen ratings firms that are presently covering the stock, Analyst Ratings News reports. Four research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $96.71.

Boulder Brands (NASDAQ:BDBD) opened at 14.43 on Friday. Boulder Brands has a 52-week low of $11.38 and a 52-week high of $18.46. The stock’s 50-day moving average is $14.1 and its 200-day moving average is $15.25. The company has a market cap of $878.7 million and a price-to-earnings ratio of 124.40.

Boulder Brands (NASDAQ:BDBD) last announced its earnings results on Thursday, May 8th. The company reported $0.01 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.07 by $0.06. The company had revenue of $122.90 million for the quarter, compared to the consensus estimate of $124.60 million. During the same quarter in the prior year, the company posted $0.07 earnings per share. The company’s quarterly revenue was up 15.2% on a year-over-year basis. On average, analysts predict that Boulder Brands will post $0.40 earnings per share for the current fiscal year.

A number of research firms have recently commented on BDBD. Analysts at TheStreet downgraded shares of Boulder Brands from a “buy” rating to a “hold” rating in a research note on Friday, May 16th. Separately, analysts at SunTrust upgraded shares of Boulder Brands from a “neutral” rating to a “buy” rating in a research note on Monday, May 12th. They now have a $23.00 price target on the stock, up previously from $15.00. Finally, analysts at Canaccord Genuity cut their price target on shares of Boulder Brands from $17.50 to $17.00 in a research note on Friday, May 9th.

Boulder Brands, Inc is a supplier of gluten-free and health and wellness products in the United States and Canada.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.